Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 585, pseudogene (RN7SL585P) is a human pseudogene corresponding to the 7SL RNA gene family[1][9][10][11]. The functional 7SL RNA is the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting secretory proteins to the endoplasmic reticulum membrane, but RN7SL585P itself is a non-functional or "dead" copy that does not code for a functional RNA or protein[7][8][5]. Numerous 7SL RNA-related sequences in the human genome exist as pseudogenes, typically arising from retrotransposition or the reverse flow of genetic information, and do not contribute to canonical SRP function[8]. While some pseudogenes can act as regulatory RNAs (such as competing endogenous RNAs or miRNA decoys), there is currently no evidence suggesting RN7SL585P has such roles[4][6]. Therefore, RN7SL585P is not considered a therapeutic target, does not have recognized biological or disease functions, and is not associated with interacting drugs or established safety considerations. Key points: - RN7SL585P is a **pseudogene**, not a protein-coding gene or functional non-coding RNA[1][9][10][11]. - It is part of the broader **7SL RNA gene family**, with the functional member acting in the signal recognition particle (SRP), but RN7SL585P does not partake in this function[5][7][8]. - There are **no validated pharmacological interactions**, biomarkers, or safety data associated because it is non-functional[1][9][10][11]. - It should not be listed as a druggable or therapeutic target; if included in a set for drug discovery, this is likely **incorrect or a misannotation**. If you require details for functional 7SL RNA or the SRP complex, additional, separate information would be needed.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 585, pseudogene (RN7SL585P).